Intercure Ltd.
INCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001857030
No open-market purchases or sales by Intercure Ltd. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $764.1K in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Intercure Ltd. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 17 | 19 | +2 |
| Shares | 3.53M | 3.15M | −375.3K (−10.6%) |
| Value | $8.92M | $6.04M | −$2.88M (−32.2%) |
New holders (4)
Institutions that held Intercure Ltd. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| AdvisorShares Investments LLC | 107,414 | $218.1K | 0.04% |
| Financial Network Wealth Advisors LLC | 1,000 | $2.01K | 0.00% |
| Simplex Trading, LLC | 180 | $0 | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 98,190 | – | – |
Sold out (2)
Institutions that held Intercure Ltd. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Mirae Asset Global Investments Co., Ltd. | 672,982 | $1.43M |
| UBS Group AG | 4,508 | $12.2K |